Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults? (SeizS100B)

  • End date
    Dec 23, 2022
  • participants needed
  • sponsor
    Centre Hospitalier Universitaire de Nīmes
Updated on 23 March 2022


Seizures represent an important clinical problem, accounting for at least 40% of adult onset epilepsy. Predicting seizure recurrence in subjects experiencing a first seizure is difficult due to the lack of prognostic biomarkers. Recent evidence has indicated that blood-brain barrier (BBB) dysfunction constitutes an etiological factor to seizures. In particular, it has been shown that modification of BBB permeability is associated with seizure activity. In addition, it was demonstrated that BBB permeability can be assessed by measuring serum level of the protein S100B. Based on these data and considerations the investigators will test whether the extent of BBB damage at time of first seizure is predictive for seizure recurrence.

The main objective of this study is to evaluate the association between the absolute (ng/ml) serum S100B levels (measured at time of the first seizure) and the experience, or not, of seizure recurrence within one year of follow-up.


The secondary objectives of this study are to investigate the:

  1. Prognostic capacity of serum S100B levels to predict seizure recurrence. B) Association between the variation (%) of serum S100B levels between first seizure episode and scheduled follow-up (D14-D28) and seizure recurrence.
  2. Correlation of S100B with IL-1b, IL-6, NSE serum levels at the same time points.
  3. Association of serology data with: a) EEG profile (normal/abnormal); b) recurrence of seizures (Y/N).
  4. Comparison of S100B serum levels in lesional vs non-lesional patients. F) Establishment of a bio-bank (serum and cells).

Condition Epilepsy, Seizures, Epileptic
Clinical Study IdentifierNCT02424123
SponsorCentre Hospitalier Universitaire de Nīmes
Last Modified on23 March 2022


Yes No Not Sure

Inclusion Criteria

The patient has been correctly informed
The patient must have given his informed and signed consent
The patient must be insured or beneficiary of a health insurance plan
The patient is at least (≥) 18 years old and less than (<) 60 years old
The patient has experienced a first generalized, epileptic seizure (patients with partial onset and secondary generalization can also be included)
The seizure has occurred less than 24 hours ago

Exclusion Criteria

The patient is participating in another study that may interfere with the results or conclusions of this study
Within the past three months, the patient has participated in another study that may interfere with the results or conclusions of this study
The patient is in an exclusion period determined by a previous study
The patient is under judicial protection
The patient refuses to sign the consent
It is impossible to correctly inform the patient
The patient is pregnant or breast-feeding (MRI contraindicated)
Patient has a previous abnormal brain imaging (MRI)
Patient has abnormal biological tests for toxicology (alcohol, cocaine and cannabis tests), blood ionogram (hyponatremia <130mM), liver enzymes (>5N), inflammatory syndrome (elevated C-reactive protein)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note